Olmesartan medoxomil 20 MG tab 30S
Ended Awarded
- Contract number
- SPE2DB26FL5ZH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,317
Award facts
- Contract value 100% obligated
- $1,316.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Olmesartan Medoxomil 20 mg tablets (30-count) with a ceiling value of $1,316.78 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a non-set-aside, competitive basis, consistent with AmerisourceBergen's established pattern of federal pharmaceutical procurement. Performance is scheduled for completion by October 28, 2025, with fulfillment from the contractor's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical supply needs across military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Under the DLA Troop Support Medical prime contract vehicle, AmerisourceBergen supplies pharmaceutical products to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. This individual delivery order for Olmesartan Medoxomil, a blood pressure medication, exemplifies the company's role in providing routine pharmaceutical commodities to support ongoing federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FL5ZH?
SPE2DB26FL5ZH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FL5ZH worth?
The government has obligated $1,317 on SPE2DB26FL5ZH.
Is contract SPE2DB26FL5ZH an order under another contract?
Yes. SPE2DB26FL5ZH is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB26FL5ZH competed?
The extent of competition for SPE2DB26FL5ZH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award